Identifying potential drug triggers for bullous pemphigoid: a disproportionality analysis of the FDA adverse event reporting system and systematic review of case reports

This study suggests a strong statistical correlation between vildagliptin, dapsone, furosemide, nivolumab, and the development of BP.

Authors

Institutions

Publication Details

Journal
Cutaneous and Ocular Toxicology
Published
2025-09-10
DOI
https://doi.org/10.1080/15569527.2025.2554799
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identifying potential drug triggers for bullous pemphigoid: a disproportionality analysis of the FDA adverse event reporting system and systematic review of case reports

R Mahesh, Kamal Maheshwari, Anoop Chanthu K. K., Krishna Undela et al.
Cutaneous and Ocular Toxicology
Autoimmune Bullous Skin Diseases
article

Identifying potential drug triggers for bullous pemphigoid: a disproportionality analysis of the FDA adverse event reporting system and systematic review of case reports

R Mahesh, Kamal Maheshwari, Anoop Chanthu K. K., Krishna Undela, Christy Thomas, Sudha Rani Kotakonda
article en

Abstract

This study suggests a strong statistical correlation between vildagliptin, dapsone, furosemide, nivolumab, and the development of BP.

Cutaneous and Ocular ToxicologyVol. 44(4)
National Institute of Pharmaceutical Education and Research (IN)
Openalex Percentile: Top 65%
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.